Eversept Partners, LP Alector, Inc. Transaction History
Eversept Partners, LP
- $1.26 Billion
- Q3 2024
A detailed history of Eversept Partners, LP transactions in Alector, Inc. stock. As of the latest transaction made, Eversept Partners, LP holds 332,756 shares of ALEC stock, worth $545,719. This represents 0.12% of its overall portfolio holdings.
Number of Shares
332,756
Previous 541,739
38.58%
Holding current value
$545,719
Previous $2.46 Million
36.84%
% of portfolio
0.12%
Previous 0.19%
Shares
3 transactions
Others Institutions Holding ALEC
# of Institutions
169Shares Held
57.8MCall Options Held
146KPut Options Held
90.8K-
Black Rock Inc. New York, NY9.1MShares$14.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.46MShares$8.95 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT4.63MShares$7.6 Million0.8% of portfolio
-
Morgan Stanley New York, NY4.36MShares$7.14 Million0.0% of portfolio
-
Jpmorgan Chase & CO New York, NY2.73MShares$4.48 Million0.0% of portfolio
About Alector, Inc.
- Ticker ALEC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 82,563,904
- Market Cap $135M
- Description
- Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...